Fergus Gleeson
About
In The Last Decade
Fergus Gleeson
293 papers receiving 12.3k citations
Hit Papers
Peers
Comparison fields: 5 of 182
- Pulmonary and Respiratory Medicine 6.9k
- Radiology, Nuclear Medicine and Imaging 3.8k
- Critical Care and Intensive Care Medicine 2.5k
- Surgery 2.1k
- Biomedical Engineering 1.8k
Countries citing papers authored by Fergus Gleeson
This map shows the geographic impact of Fergus Gleeson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fergus Gleeson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fergus Gleeson more than expected).
Fields of papers citing papers by Fergus Gleeson
This network shows the impact of papers produced by Fergus Gleeson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fergus Gleeson. The network helps show where Fergus Gleeson may publish in the future.
Co-authorship network of co-authors of Fergus Gleeson
This figure shows the co-authorship network connecting the top 25 collaborators of Fergus Gleeson. A scholar is included among the top collaborators of Fergus Gleeson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fergus Gleeson. Fergus Gleeson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 35 | |
| 2 | 52 | |
| 3 | 42 | |
| 4 | 82 | |
| 5 | 7 | |
| 6 | Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis breakdown → | 212 |
| 7 | 15 | |
| 8 | 105 | |
| 9 | 6 | |
| 10 | 11 | |
| 11 | Decision theory and cost-benefit analysis of re-staging oesophageal cancer after neoadjuvant chemotherapy with PET-CT rather than CT | 2 |
| 12 | Validation Of 4 Models To Estimate The Probability Of Malignancy In Patients With Sub-Centimeter Pulmonary Nodules | 1 |
| 13 | SUVmax assessment of mediastinal nodes in non-small cell lung cancer using a novel penalised likelihood PET reconstruction | 1 |
| 14 | Test-retest reproducibility of [F-18]fluciclatide PET imaging in subjects with solid tumors | 0 |
| 15 | Inhibition of p38 Mitogen-Activated Protein Kinase Attenuates Vascular and Systemic Inflammation in Patients with Atherosclerosis as Assessed by 18-F Fluorodeoxyglucose PET-CT | 3 |
| 16 | 5 | |
| 17 | Clinical utility of ultrasound in detecting malignant pleural disease in the presence of a pleural effusion | 1 |
| 18 | 146 | |
| 19 | 174 | |
| 20 | 14 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.